Transplant Patients

Algorithm illuminates need of high-volume hospitals

Using the results from a computerized mathematical model, Johns Hopkins researchers investigated whether they could improve heart and lung transplantation procedures by transferring patients from low-volume to high-volume transplant centers.

Researchers used a simulation to transfer patients from low-volume to...
Researchers used a simulation to transfer patients from low-volume to high-volume transplant centers as a way to show that standardized care from the high-volume centers can save lives.
Source: Johns Hopkins Medicine

Investigators have long observed a positive relationship between a high operative volume and improved patient outcomes across a variety of surgical procedures, meaning that the more times a medical center does a particular surgery, the better its patients do overall. The new study was the first to investigate this trend for heart and lung transplant patients on a national level, the Johns Hopkins team says.

“The reason we did the simulation is because there is a lot of uncertainty in predicting post-transplantation outcomes,” says Trent Magruder, M.D., a surgery resident and fellow in the Division of Cardiac Surgery at the Johns Hopkins University School of Medicine. “We hope our model will help illuminate areas for improvement and bring better and more predictable outcomes to doctors and patients.”

Past research showed that centers performing less than 14 heart transplants or 20 lung transplants each year have been associated with increased patient mortality. The new simulation drew on information from 12,594 heart transplant patients from 135 medical centers and 12,300 lung transplant patients from 67 centers in the U.S. The researchers define low-volume centers as those performing less than an average of 5.9 heart transplants or 11.9 lung transplants per year — both below the threshold for low-volume centers, as defined by past studies by other researchers.

The algorithm divided the continental United States into 11 regions, as defined by the United Network for Organ Sharing, which controls the allocation of donor organs, and began figuratively “closing” the center with the lowest number of transplants per year in each region. The algorithm essentially referred all patients from the “closed” low-volume center to the largest one in that region and assigned those patients the largest center’s reported mortality rate. This process was repeated until either five centers had been closed or only one transplant center in a given region was left.

For heart transplant patients, the first, second, third, fourth and fifth closings were associated with saving 10.1, 37.5, 76.6, 120 and 240.3 lives, respectively, at one year post-transplant. Lung transplant patients saw similar benefits, with 29.2, 78.2, 124.6, 202.5 and 240 lives saved at one year post-transplant for each successive closing.

“The goal of this study is not to say we need to close small centers,” says Christian Merlo, M.D., M.P.H., associate professor of medicine at Johns Hopkins. “We used this algorithm as a tool to see if we can limit some of the heterogeneity between centers and find out if this improves outcomes for our patients. It is food for thought that we hope will spark conversation among our colleagues about the need for a set of best practices and ways to share that information across centers,” he adds.

While other countries, like the U.K., have nationalized, single-payer health care, a similar system may not be practical in the U.S. because of its size. For example, patients’ average travel distances for heart and lung transplantation exceed 300 miles in parts of the Pacific Northwest, and center closure would undoubtedly increase these distances. As such, regionalization could limit access to care to those who can’t afford to travel, in addition to the cost of the procedure. The authors emphasize that their algorithm, for the time being, can’t quantify the socioeconomic costs regionalization of care would create.

The researchers say that the next steps will include studying the best performing centers to see what they are doing differently from smaller centers to save more lives. Using this information, transplant physicians and surgeons can develop guidelines for best practices to share across the country. “The limitation of this study is that it is a black box,” says Magruder. “I can tell you that this algorithm appears to save lives, but I can’t tell you what the high-volume centers are doing, which makes more detailed research an important next step.”


Source: Johns Hopkins Medicine

19.09.2016

Read all latest stories

Related articles

Photo

Article • LTX overview

Lung transplant surgery: last hope for patients with advanced lung diseases

Despite treatment, chronic lung diseases such as COPD or cystic fibrosis can become so severe that a lung transplant is necessary. Dr Urte Sommerwerck explains which patients might be considered for…

Photo

Article • Keratoplasty

Corneal transplantation surgery: AI for an eye

Many consider our eyes to be the windows to the soul. Yet the cornea, the panes of these windows, sometimes need significant repair. Friso Heslinga, PhD, created artificial intelligence models to…

Photo

News • Donation after cardiac death

'Heart in a box' technology gives hope to transplant patients

A new heart transplant technique, which allows surgeons to transplant donor hearts that have stopped beating after death, is reducing waiting lists for patients in Australia and potentially around…

Related products

Synapse 3D

Reading

Fujifilm · Synapse 3D

FUJIFILM Europe GmbH
Advanced Edge Enhancement

Accessories / Complementary Systems

Canon · Advanced Edge Enhancement

Canon Medical Components Europe B.V.
Alsachim – Dosimyco immunosupressant reagent kit (RUO)

Clinical Chemistry

· Alsachim – Dosimyco immunosupressant reagent kit (RUO)

Alsachim, a Shimadzu Group Company
Amulet Bellus II

Mammo Workstations

Fujifilm · Amulet Bellus II

FUJIFILM Europe GmbH
Arcovis 3000 S / R

Surgical II-C-Arms

Villa Sistemi Medicali · Arcovis 3000 S / R

VILLA SISTEMI MEDICALI s.p.a.
Beckman Coulter – DxONE Command Central Workstation

LIS, Middleware, POCT

· Beckman Coulter – DxONE Command Central Workstation

Beckman Coulter Diagnostics
Subscribe to Newsletter